Related Experiment Video
Updated: Jun 9, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Arrhythmias May Hide a Genetic Cardiomyopathy in Left Ventricular Hypertrabeculation in Children: A Single-Center
Irma Battipaglia1, Nicoletta Cantarutti1, Marianna Cicenia1
1Pediatric Cardiology and Cardiac Arrhythmias Complex Unit, Bambino Gesù Children's Hospital IRCCS, 00050 Rome, Italy.
Insights
Left ventricular hypertrabeculation (LVHT) in children can cause arrhythmias in 23.6% of cases, though outcomes are generally good. Genetic variants are linked to these arrhythmic manifestations in pediatric LVHT patients.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Genetics
Background:
- Left ventricular hypertrabeculation (LVHT) is a myocardial disorder with variable clinical presentations, ranging from asymptomatic to severe heart failure.
- Distinguishing between benign and pathological forms of LVHT remains a clinical challenge.
- Arrhythmias, thromboembolic events, and sudden cardiac death (SCD) are potential complications of LVHT.
Purpose of the Study:
- To investigate the prevalence and types of arrhythmic manifestations in a large pediatric cohort with LVHT.
- To correlate arrhythmic events with genetic findings and other clinical markers in pediatric patients with LVHT.
- To assess the clinical outcomes in pediatric patients diagnosed with LVHT.
Main Methods:
- Retrospective analysis of 140 pediatric patients diagnosed with LVHT between 2013 and 2023.
- Collection of data on family history, instrumental examinations, cardiac magnetic resonance imaging, and genetic testing.
- Evaluation of clinical outcomes, including the occurrence of arrhythmias and need for interventions like implantable cardioverter-defibrillators (ICDs).
Main Results:
- Arrhythmias were identified in 33 (23.6%) pediatric patients, including supraventricular tachyarrhythmias, ventricular arrhythmias (VT, VF, PVCs), sinus node dysfunction, and atrioventricular blocks (AVB).
- A significant association was found between the presence of arrhythmias and genetic variants of class 4 or 5 (p = 0.037).
- Three patients required an implantable cardioverter-defibrillator (ICD); no cases of sudden cardiac death (SCD) were reported.
Conclusions:
- Arrhythmias are a significant concern in pediatric patients with LVHT, occurring in nearly a quarter of the cohort.
- Genetic variants may play a role in the development of arrhythmias in pediatric LVHT.
- Despite the prevalence of arrhythmias, the overall outcomes in this pediatric cohort were favorable, with no reported SCD.
Background:
Left ventricular hypertrabeculation (LVHT) is a myocardial disorder with different clinical manifestations, from total absence of symptoms to heart failure, arrhythmias, sudden cardiac death (SCD), and thromboembolic events. It is challenging to distinguish between the benign and pathological forms of LVHT. The aim of this study was to describe the arrhythmic manifestations of LVHT in a large group of pediatric patients and to correlate them with genetic results or other clinical markers.
Methods:
We retrospectively enrolled 140 pediatric patients with diagnosis of LVHT followed at our Institution from 2013 to 2023. Data regarding family history, instrumental exams, cardiac magnetic resonance, genetic testing and outcomes were collected. Most of them had isolated LVHT (80.7%); in other patients, mixed phenotypes (hypertrophic or dilated cardiomyopathy or congenital heart disease) were present.
Results:
Arrhythmias were found in 33 children (23.6%): 13 (9.3%) supraventricular tachyarrhythmias; 14 (10%) ventricular arrhythmias (five frequent PVCs (premature ventricular contractions), eight patients with ventricular tachycardia (VT), one ventricular fibrillation (VF)); two (1.4%) sinus node disfunctions; two (1.4%) complete atrio-ventricular blocks (AVB), three (2.1%) paroxysmal complete AVB, one (0.7%) severe I degree AVB. Three patients received an ICD (implantable cardioverter defibrillator). Comparison between LVHT patients with (33 pts) and without (107 pts) arrhythmias as regards genetic testing showed a statistical significance for the presence of class 4 or 5 genetic variants and arrhythmic manifestation (p = 0.037).
Conclusions:
In our pediatric cohort with LVHT, good outcomes were observed, but arrhythmias were not so rare (23.6%); no SCD occurred.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy I: Introduction and Classification
Dysrhythmias IV: Characteristics of Bradyarrhythmias

